Don’t close the book on tocilizumab for the treatment of severe COVID-19 pneumonia–the jury is still out: The Kuwait experience

PURPOSE: This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in three of Kuwait’s largest public hospitals City. PATIENTS AND METHODS: This chart...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shamali, Yousef, M. Ali, Yaser, Al-Shamali, Rawan A., Al-Melahi, Maryam, Al-Shammari, Farah R., Alsaber, Ahmad, Al-Adsani, Wasl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384154/
https://www.ncbi.nlm.nih.gov/pubmed/34428204
http://dx.doi.org/10.1371/journal.pone.0254379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384154/
https://www.ncbi.nlm.nih.gov/pubmed/34428204
http://dx.doi.org/10.1371/journal.pone.0254379

Ejemplares similares